-
The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission
2019 Aug 16, 7:33am | 1752Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) Novocure Ltd (NASDAQ: NVCR) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 15) AbbVie Inc (NYSE: ABBV) Acer Therapeutics Inc (...
-
The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings
2019 Aug 15, 7:45am | 1521Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) GENMAB A/S/S ADR (NASDAQ: GMAB) (announced first-half results and raised 2019 guidance) Down In The Dumps (Biotech stocks hitting 52-week lows...
-
The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering
2019 Aug 14, 7:50am | 1602Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 13) GENMAB A/S/S ADR (NASDAQ: GMAB) (IPOed July 1) NextCure Inc (NASDAQ: NXTC)(reacted to its second-quarter results) Novocure Ltd (NASDAQ: NVCR)...
-
What Caused The Opening Gap In Inpixon?
2019 Aug 13, 10:15am | 247Read More...For real-time updates on INPX, beat the news and login or try Benzinga Pro. Inpixon (NASDAQ: INPX) today had a large opening gap of -63.50%. Photo taken from the Opening Gap Signals tool inside Benzinga Pro. Why Is INPX Moving? Inpixon shares are trading lower after the company announced a 6.497...
-
The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results
2019 Aug 13, 7:25am | 1408Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 12) GENMAB A/S/S ADR (NASDAQ: GMAB) (IPOed July 1) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 13) Acer Therapeutics Inc (...
-
Expert Take On PG&E Equity Offering, Bankruptcy Outlook
2019 Aug 08, 1:41pm | 772Read More...PG&E Corporation (NYSE: PCG) shares jumped 4% Thursday following a new filing that revealed shareholders have agreed to a $15 billion offering to help the company pay for its reorganization efforts. PG&E stock has had a rollercoaster year as investors try to navigate the company’...
-
The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering
2019 Aug 08, 7:11am | 2185Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 7) Akero Therapeutics Inc (NASDAQ: AKRO) Allakos Inc (NASDAQ: ALLK) Cytokinetics, Inc. (NASDAQ: CYTK) Guardant Health Inc (NASDAQ: GH) (reacted to...
-
What Caused The Opening Gap In DPW?
2019 Aug 07, 9:57am | 257Read More...For real-time updates on DPW, beat the news and login or try Benzinga Pro. DPW Holdings (NASDAQ: DPW) today had a large opening gap of -42.18%. Photo taken from the Opening Gap Signals tool inside Benzinga Pro. Why Is DPW Moving? DPW Holdings shares are trading lower after the company reported a...
-
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
2019 Aug 07, 7:34am | 2564Read More...Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 6) Allakos Inc (NASDAQ: ALLK)(announced common stock offering) Cytokinetics, Inc. (NASDAQ: CYTK) Insulet Corporation (NASDAQ: PODD)( reacted to...
-
The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
2019 Aug 06, 7:22am | 2990Read More...Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks No biotech stocks hit 52-week highs Monday. Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 5) Acer Therapeutics Inc (NASDAQ: ACER) Aclaris Therapeutics Inc (NASDAQ: ACRS)...
-
The Week In Cannabis: Aphria's Earnings, New York's Decriminalization, Crapo's Support, Pirro's Involvement
2019 Aug 04, 8:30am | 4688Read More...New York Gov. Andrew Cuomo signed a bill to decriminalize cannabis use and expunge all criminal penalties for possession of 2 ounces or less of marijuana. Meanwhile, Sen. Mike Crapo (R-ID) came out in support of federal banking protections for state legal cannabis businesses, a federal court...
-
Why Beyond Meat Is Trading Way Above Its $160 Offering Price
2019 Aug 01, 12:12pm | 624Read More...Beyond Meat Inc (NASDAQ: BYND) shares tanked another 10% on Thursday after the company priced its recently announced 3.25 million-share secondary offering at $160, more than a 30% discount to the stock’s $234 closing price last week. Despite the market disappointment with the pricing, the $...
-
The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings
2019 Aug 01, 7:18am | 1714Read More...Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 1) Grifols SA - ADR ADR Class B (NASDAQ: GRFS) Odonate Therapeutics Inc (NASDAQ: ODT) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) Down In The Dumps (...
-
What Caused The Opening Gap In Sigma Labs?
2019 Jul 31, 9:48am | 249Read More...For real-time updates on SGLB, beat the news and login or try Benzinga Pro. Sigma Labs (NASDAQ: SGLB) today had a large opening gap of -61.54%. Photo taken from the Opening Gap Signals tool inside Benzinga Pro. Why Is SGLB Moving? Sigma Labs shares are trading lower after the company announced a...
-
Analyst Reacts To Beyond Meat Earnings, Offering
2019 Jul 29, 8:23pm | 250Read More...Bernstein's Alexia Howard shared with the viewers of CNBC's "Fast Money" her reaction to Beyond Meat Inc (NASDAQ: BYND) earnings and the secondary offering. She said the quarter came in pretty strongly, better than analysts estimated. Sales were strong, profits were good...
